Helicobacter pylori: From bench to bedside

Canadian Journal of Gastroenterology

Volumn 11, Issue 7, 1997, Pages 589-596

  Chiba, N ^b   Matisko, A ^b   Sinclair, P ^b   Thomson, A B R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE

Author keywords

Diagnosis; Epidemiology; Gastroduodenal pathology; Helicobacter pylori; Immunization; Practice guidelines; Treatment

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH; CLARITHROMYCIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROTON PUMP INHIBITOR; TETRACYCLINE; UREASE;

BACTERIAL INFECTION; CANADA; COST CONTROL; DUODENUM ULCER; DYSPEPSIA; EUROPE; GASTRITIS; GOOD CLINICAL PRACTICE; HEALTH CARE COST; HELICOBACTER PYLORI; HUMAN; INTRANASAL DRUG ADMINISTRATION; LYMPHOMA; NONHUMAN; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION; REVIEW; STOMACH CANCER; STOMACH DISEASE; STOMACH ULCER;

EID: 0030716165     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1997/975469     Document Type: Review

References (11)

1. Joossens JV, Hill MJ, Elliott P, et al. Dietary salt, nitrate and stomach mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Int J Epidemiol 1996;25:494-504.
2. Uemura N, Okamoto S, Mukai T, et al. Effect of Helicobacter pylori eradication on the healing and recurrence of peptic ulcer: combination therapy with low-dose omeprazole and clarithromycin. Eur J Gastroenterol Hepatol 1995;7(SuPPl 1):S67-9.
3. Patel P, Mendall MA, Khulusi S, Northfield TC, Strachan DP. Helicobacter pylori in childhood: risk factors and effect on growth. BMJ 1994;309:1119-23.
4. Patel P, MA Mendall, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995;371:711-4
5. Murray, Bamford KB, O'Reilly DP, McCrum EE, Evans AE. Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class Br Heart J 1995;74:497-501.
6. Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB. Survey of patients with upper gastrointestinal tract dyspepsia. A trial of H blocker therapy or endoscopy - a randomized trial of 2 management methods. Ugeskr Laeger 1995;157:893-7.
7. Fendrick AM, Chernew ME, Hirth RA, Bloom, BS. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med 1995;123:260-8.
8. Sonnenberg A. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects. Am J Gastroenterol 1996;91:1773-7.
9. Fallone CA, Loo VG, Barkun AN, De Souza E, Lavallee J, Wickham C. Rate of Helicobacter pylori resistance to metronidazole, clarithromycin and six other agents. Can J Gastroenterol 1996;10(Suppl A):30A.
10. Kuipers EJ, Lundell L, Klinkenberg-Knol EC. Atrophic gastritis and Helicobacter pylori infections in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334:1018-22.
11. Tytgat GN. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994;8:359-68.